Polypharmacy
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: [Patients] Hospitalized patients aged 65 years or older at Kawasaki Municipal Tama Hospital Patients taking five or more regular oral medications continuously for at least 4 weeks Patients who provide written informed consent [Healthcare professionals] Physicians, pharmacists, or nurses working at Kawasaki Municipal Tama Hospital Healthcare professionals routinely involved in medication management for older adults Individuals who provide written informed consent
Exclusion criteria
Exclusion criteria: [Patients] Patients with severe cognitive impairment, severe psychiatric illness, acute illness, or other conditions causing serious communication difficulties Patients judged by the principal investigator to have excessive burden or disadvantage associated with study participation Patients otherwise judged inappropriate for participation by the principal investigator [Healthcare professionals] Individuals considered unable to adequately participate in study evaluation procedures Individuals otherwise judged inappropriate for participation by the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Japanese version of the System Usability Scale (SUS) score assessed immediately after use of the MPEG Plus prototype system | — |
Secondary
| Measure | Time frame |
|---|---|
| Free-text feedback regarding usability, understandability, and utility assessed immediately after use of the MPEG Plus prototype system. Five-point self-assessment of reference frequency and perceived usefulness of OPT and D-Aid information assessed immediately after use of the MPEG Plus prototype system. Changes in medication review decisions and details of modifications assessed during the field evaluation period. Reference frequency of OPT, D-Aid information, and nudge messages assessed during the field evaluation period. Time required for medication review decision-making assessed during the field evaluation period. Qualitative evaluation of feasibility, acceptability, and operational challenges based on focus group interviews conducted after completion of the field evaluation period. | — |
Countries
Japan
Contacts
St. Marianna University School of Medicine Department of General Internal Medicine